Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

EHC stock hub

Encompass Health Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EHCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.5B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

EHC

In the news

Latest news · EHC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.4

P25 12.3P50 18.4P75 33.1

Trailing P/E18.2

P25 14.9P50 23.2P75 38.5

ROE25.2

P25 -105.6P50 -46.5P75 -3.1

ROIC14.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EHC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

277

Groups with data

Currency

USD

Showing 277 of 277 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000785161
Company name	Encompass Health Corporation
Country	United States
Country code	US
Cusip	29261A100
Employees	42,300
Employees Change	2,225%
Employees Change Percent	5.55
Enterprise value	$13.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	1986-09-30
Isin	US29261A1007
Last refreshed	2026-05-10
Market cap	$10.5B
Market cap category	Large-Cap
Price	$106
Price currency	USD
Rev Per Employee	143,413.71x
Sector	Healthcare
Sic	8060
Symbol	EHC
Website	https://www.encompasshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.77%
EV Earnings	21.73x
EV Sales Forward	2x
EV/EBIT	12.14x
EV/EBITDA	9.27x
EV/FCF	28.43x
EV/Sales	2.18x
FCF yield	4.41%
Forward P/E	17.37x
P/B ratio	4.18x
P/E ratio	18.19x
P/S ratio	1.73x
PE Ratio10 Y	19.94x
PE Ratio3 Y	20.88x
PE Ratio5 Y	19.95x
PEG ratio	1.73x
PS Forward	1.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.93%
EBITDA Margin	23.47%
FCF margin	7.66%
Gross margin	43.49%
Gross Profit	$2.6B
Gross Profit Growth	13.8%
Gross Profit Growth Q	11.62%
Gross Profit Growth3 Y	13.41%
Gross Profit Growth5 Y	7.99%
Net Income	$607.6M
Net Income Growth	23.15%
Net Income Growth Q	28.38%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	31.14%
Net Income Growth5 Y	14.87%
Pretax Margin	16.54%
Profit Margin	10.04%
Profit Per Employee	$14,364
Profitable Years	19
ROA	9.74
Roa5y	7.72
ROCE	16.9
ROE	25.23
Roe5y	21.15
ROIC	14.42
Roic5y	11.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.17%
Cagr15y	12.95%
Cagr1y	-9.09%
Cagr20y	10.39%
Cagr3y	20.2%
Cagr5y	10.5%
Div CAGR10	-1.94%
Div CAGR3	0.45%
Div CAGR5	-7.95%
EPS Growth	23.57
EPS Growth Q	30.3
EPS Growth Quarters	9
EPS Growth Years	3
EPS Growth3 Y	30.38
EPS Growth5 Y	14.45
FCF Growth	20.19%
FCF Growth Q	20.08%
FCF Growth3 Y	47.81%
FCF Growth5 Y	1.9%
OCF Growth	14.01%
OCF Growth Q	8.49%
OCF Growth10 Y	8.07%
OCF Growth3 Y	18.85%
OCF Growth5 Y	7.55%
Revenue Growth	10.05x
Revenue Growth Q	9.02x
Revenue Growth Quarters	15x
Revenue Growth Years	5x
Revenue Growth3 Y	10.88x
Revenue Growth5 Y	5.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.87
Assets	$7.3B
Cash	$110.5M
Current Assets	$1B
Current Liabilities	$876.8M
Debt	$2.8B
Debt EBITDA	$1.88
Debt Equity	$0.83
Debt FCF	$6.01
Equity	$3.4B
Interest Coverage	8.83
Liabilities	$3.9B
Long Term Assets	$6.3B
Long Term Liabilities	$3.1B
Net Cash	$-2.7B
Net Cash By Market Cap	$-25.45
Net Debt EBITDA	$1.88
Net Debt Equity	$0.8
Net Debt FCF	$5.77
Tangible Book Value	$903.8M
Tangible Book Value Per Share	$9.09
WACC	6.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Net Working Capital	$111.6M
Quick ratio	0.9
Working Capital	$152.3M
Working Capital Turnover	$58.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	12.12%
Dividend Growth Years	1%
Dividend per share	$0.76
Dividend Years	14
Dividend Yield	0.72%
Ex Div Date	2026-07-01
Last Dividend	$0.19
Payout Frequency	Quarterly
Payout Ratio	12.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	276.18%
1Y total return	-9.08%
200-day SMA	111.4
3Y total return	73.7%
50-day SMA	103.2
50-day SMA vs 200-day SMA	50under200
5Y total return	64.7%
All Time High	154.1
All Time High Change	-31.13%
All Time High Date	1998-04-20
All Time Low	0.35
All Time Low Change	30,214.29%
All Time Low Date	2003-03-31
ATR	3.11
Beta	0.58
Beta1y	0.53
Beta2y	0.57
Ch YTD	-0.04
High	108.6
High52	128
High52 Date	2025-10-24
High52ch	-17.1%
Low	105.9
Low52	92.77
Low52 Date	2026-02-03
Low52ch	14.37%
Ma50ch	2.78%
Price vs 200-day SMA	-4.74%
RSI	55.34
RSI Monthly	53.24
RSI Weekly	49.42
Sharpe ratio	-0.39x
Sortino ratio	-0.33
Total Return	1.06%
Tr YTD	0.34
Tr15y	521.67%
Tr1m	0.41%
Tr1w	-1.28%
Tr3m	0.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	3
Analyst Price Target Top	$143
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.5
Earnings EPS Estimate Growth	9.49
Earnings Revenue Estimate	1,568,130,768x
Earnings Revenue Estimate Growth	7.78x
Operating Income	$1.1B
Operating Income Growth	17.72
Operating Income Growth Q	12.96
Operating Income Growth3 Y	18.35
Operating Income Growth5 Y	10.09
Operating margin	17.93
Price target	$144
Price Target Change	$35.88
Price Target Change Top	$35.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,944,120%
Float Percent	98.73%
Net Borrowing	81,000,000
Shares Insiders	1.02%
Shares Institutions	99.82%
Shares Out	99,199,080
Shares Qo Q	-1.37%
Shares Yo Y	-0.34%
Short Float	3.12%
Short Ratio	3.16
Short Shares	3.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$405.9M
Average Volume	1,002,500.2x
Bv Per Share	25.37
CAPEX	$-735.7M
Ch10y	158.8
Ch15y	302.7
Ch1m	0.41
Ch1w	-1.28
Ch1y	-9.69
Ch20y	367.4
Ch3m	0.67
Ch3y	69.87
Ch5y	24.3
Ch6m	-7.96
Change	-0.98%
Change From Open	-1.49
Close	107.2
Days Gap	0.51
Depreciation Amortization	336,000,000
Dollar Volume	102,665,967.4
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$1.1B
EBITDA	$1.4B
EPS	$5.98
F Score	7
FCF	$464.4M
FCF EV Yield	3.52x
FCF Per Share	$4.68
Financing CF	-403,300,000
Fiscal Year End	December
Founded	1,983
Goodwill	1,317,600,000
Graham Number	58.43829
Graham Upside	-44.92
Income Tax	$207.7M
Investing CF	-756,200,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2006-10-26
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Lynch Fair Value	$88.96
Lynch Upside	-16.15
Ma150	108.3
Ma150ch	-2.02%
Ma20	104.5
Ma20ch	1.57%
Net CF	40,600,000
Next Earnings Date	2026-08-03
Open	107.7
Optionable	Yes
P FCF Ratio	22.66
P OCF Ratio	8.77
Payment Date	2026-04-15
Position In Range	8.3
Ppne	4,421,800,000
Price Date	2026-05-08
Price EBITDA	$7.39
Ptbv Ratio	11.65
Relative Volume	0.97x
Revenue	6,066,400,000x
SBC By Revenue	0.96x
Share Based Comp	58,500,000
Tax By Revenue	3.42x
Tax Rate	20.71%
Tr20y	621.63%
Tr6m	-7.61%
Us State	Alabama
Volume	967,634
Z Score	3.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

EHC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.76 annual per share

Payout ratio

+12.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-8.0%

1 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2026-07-01

Performance

EHC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EHC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.8%

Float: +98.7% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EHC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.3

Neutral momentum band

Price vs 200-day MA

-4.7%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

-0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EHC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EHC stock rating?

Encompass Health Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EHC analysis?

The full report lives at /stocks/EHC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EHC?

The latest report frames EHC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EHC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.